Cargando…

Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma

The overall survival of patients with multiple myeloma (MM) has been improved greatly over the last 2 decades with the broader use of novel drugs and autologous tandem transplantation. However, more than one tenth of myeloma patients still die shortly after diagnosis. We therefore aim to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Pei, Lin, Ting-Wei, Gau, Jyh-Pyng, Yu, Yuan-Bin, Hsiao, Liang-Tsai, Tzeng, Cheng-Hwai, Chen, Po-Min, Chiou, Tzeon-Jye, Liu, Jin-Hwang, Liu, Yao-Chung, Liu, Chia-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	4800
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058940/ https://www.ncbi.nlm.nih.gov/pubmed/26683968 http://dx.doi.org/10.1097/MD.0000000000002305

Ejemplares similares

Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study
por: Hsiao, Liang-Tsai, et al.
Publicado: (2015)

A “Bone Marrow Score” for Predicting Hematological Disease in Immunocompetent Patients With Fevers of Unknown Origin
por: Wang, Hao-Yuan, et al.
Publicado: (2014)

Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients
por: Hsiao, Liang-Tsai, et al.
Publicado: (2016)

Risk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myeloma
por: Huang, Chun-Teng, et al.
Publicado: (2017)

Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma
por: Lin, Chia-Hsin, et al.
Publicado: (2019)

Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes
por: Teng, Chung-Jen, et al.
Publicado: (2011)

The uniqueness of morphological features of pure erythroid leukemia in myeloid neoplasm with erythroid predominance: A reassessment using criteria revised in the 2016 World Health Organization classification
por: Ko, Po-Shen, et al.
Publicado: (2017)

Combined immune score predicts the prognosis of newly diagnosed multiple myeloma patients in the bortezomib-based therapy era
por: Wei, Min, et al.
Publicado: (2021)

Herpes zoster prophylaxis: Essential for treating newly diagnosed multiple myeloma patients
por: Lin, Wen‐Ying, et al.
Publicado: (2022)

Prognostic Factors on the Graft-versus-Host Disease-Free and Relapse-Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation
por: Liu, Yao-Chung, et al.
Publicado: (2016)

Correction: Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients
por: Chen, Chien-Ting, et al.
Publicado: (2018)

Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients
por: Chen, Chien-Ting, et al.
Publicado: (2017)

The risk of early mortality in elderly patients with newly diagnosed acute myeloid leukemia
por: Liu, Chia‐Jen, et al.
Publicado: (2020)

Long‐term outcomes of frontline intensification in primary CNS lymphoma: A real‐world single‐center experience
por: Wang, Hao‐Yuan, et al.
Publicado: (2023)

Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China
por: Yao, Rongxin, et al.
Publicado: (2019)

Analysis of early death in newly diagnosed acute promyelocytic leukemia patients
por: Xu, Fang, et al.
Publicado: (2017)

Risk factors and clinical features for post-transplant thoracic air-leak syndrome in adult patients receiving allogeneic haematopoietic stem cell transplantation
por: Liu, Yao-Chung, et al.
Publicado: (2019)

Primary bone marrow lymphoma: A hematological emergency in adults with fever of unknown origin
por: Wang, Hao‐Yuan, et al.
Publicado: (2018)

A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma
por: Liu, Chia‐Jen, et al.
Publicado: (2020)

Bortezomib-based regimens improve the prognosis of newly diagnosed MM patients with chromosomal aberrations except for del(17q13): A retrospective study from a single center
por: Liu, Zhigang, et al.
Publicado: (2021)

Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients
por: Qin, Ya-Zhen, et al.
Publicado: (2016)

The influence of high-efficiency particulate air filtration on mortality among multiple myeloma patients receiving autologous stem cell transplantation
por: Tsai, Chun-Kuang, et al.
Publicado: (2021)

Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma: A Retrospective Analysis of 229 Patients
por: Jian, Yuan, et al.
Publicado: (2016)

Treatment-related acute granulocyte–monocytic leukemia from multiple myeloma: A case report and literature review
por: Qian, Juan, et al.
Publicado: (2017)

Synchronous diagnosis of anaplastic large cell lymphoma and multiple myeloma in a patient: A case report
por: Shi, Xiaofeng, et al.
Publicado: (2020)

Soluble vascular cell adhesion molecular-1 is a potential biological indicator of hemophilic arthropathy
por: Tseng, Yu-Hsin, et al.
Publicado: (2016)

Nasopharyngeal Lymphoma: A 22-Year Review of 35 Cases
por: Hsueh, Chien-Yu, et al.
Publicado: (2019)

Diagnostic Pitfalls of Discriminating Lymphoma-Associated Effusions
por: Chen, Hung-Jen, et al.
Publicado: (2015)

Recombinant human thrombopoietin improves the efficacy of intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor in mobilizing peripheral blood stem cells in patients with multiple myeloma: A cohort study
por: Wang, Guorong, et al.
Publicado: (2017)

MiRNAs with prognostic significance in multiple myeloma: A systemic review and meta-analysis
por: Xu, Peipei, et al.
Publicado: (2019)

Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma: A case report and literature review
por: Mendes, Fernanda Rodrigues, et al.
Publicado: (2020)

Case report: simultaneous occurrence of multiple myeloma and non-Hodgkin lymphoma treated by CAR T therapy
por: Li, Tongjuan, et al.
Publicado: (2020)

Huanglian Jiedu Decoction for treatment of multiple myeloma: A protocol for a systematic review and meta-analysis
por: An, Na, et al.
Publicado: (2020)

Coexistence of nodal marginal zone B-cell lymphoma and multiple myeloma: A case report and literature review
por: Wang, Manzhi, et al.
Publicado: (2022)

Efficacy and safety of daratumumab in the treatment of relapsed/refractory multiple myeloma: A meta-analysis of randomized controlled trials
por: Huang, Zeng-Yi, et al.
Publicado: (2023)

Bortezomib-based treatment for multiple myeloma patients with renal impairment: A systematic review and meta-analysis of observational studies
por: Zhu, Wanqiu, et al.
Publicado: (2016)

Coexistence of primary mediastinal MALT lymphoma and multiple myeloma like POEMS syndrome: A case report and literature review
por: Yin, Shangjin, et al.
Publicado: (2023)

Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma: A case report
por: Zuo, Wenli, et al.
Publicado: (2017)

Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients
por: Hsu, Te-Lin, et al.
Publicado: (2022)

Interleukin-6 gene-174 G/C promoter polymorphism is not associated with multiple myeloma susceptibility: evidence from meta-analysis: A systematic review and meta-analysis
por: Dong, Xiaohui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i473k4ovtj5vtsgnp5bbo6pcm3